1:2:1 Podcast

New hope in treating cancer

Last month, Silicon Valley entrepreneur and philanthropist Sean Parker announced the launch of the new Parker Institute for Cancer Immunotherapy, a multi-institution effort established with a $250 million grant from his foundation. Stanford Medicine will be one of the institute’s six university-based research centers that will use the grant to advance the field of cancer immunotherapy. In this podcast, Crystal Mackall, MD, associate director of the Stanford Cancer Institute and co-medical director of the Stanford Laboratory for Cell and Gene Medicine, discusses the efforts here at Stanford. 

Photo by Paul Keitz

Length: 30 mins. 6 sec.

Leading in Precision Health

Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise. 

A Legacy of Innovation

Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.